» Authors » Coen R N Rasch

Coen R N Rasch

Explore the profile of Coen R N Rasch including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 111
Citations 1612
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nuijens A, Oei A, Franken N, Rasch C, Stalpers L
Curr Oncol . 2025 Jan; 32(1). PMID: 39851963
Normal tissue reactions vary significantly among patients receiving the same radiation treatment regimen, reflecting the multifactorial etiology of late radiation toxicity. Predicting late radiation toxicity is crucial, as it aids...
2.
de Leeuw A, Giralt J, Tao Y, Benavente S, Nguyen T, Hoebers F, et al.
Radiother Oncol . 2024 Nov; 202:110612. PMID: 39522824
Purpose: To report on quality assurance (QA) and protocol adherence (PA) in a multicentre phase III trial for head and neck cancer, evaluate patterns of protocol deviations and investigate the...
3.
Klaassen L, Jaarsma-Coes M, Marinkovic M, Luyten G, Rasch C, Ferreira T, et al.
Invest Ophthalmol Vis Sci . 2024 Sep; 65(11):17. PMID: 39250118
Purpose: Perfusion-weighted imaging (PWI; magnetic resonance imaging [MRI]) has been shown to provide valuable biological tumor information in uveal melanoma (UM). Clinically used semiquantitative methods do not account for tumor...
4.
Nuijens A, Oei A, Koster L, Hoebe R, Franken N, Rasch C, et al.
Radiat Oncol . 2024 Sep; 19(1):116. PMID: 39223539
Background: A predictive assay for late radiation toxicity would allow more personalized treatment planning, reducing the burden of toxicity for the more sensitive minority, and improving the therapeutic index for...
5.
de Leeuw A, Giralt J, Tao Y, Benavente S, France Nguyen T, Hoebers F, et al.
Radiother Oncol . 2024 Apr; 196:110281. PMID: 38636708
Background And Purpose: This multicenter randomized phase III trial evaluated whether locoregional control of patients with LAHNSCC could be improved by fluorodeoxyglucose-positron emission tomography (FDG-PET)-guided dose-escalation while minimizing the risk...
6.
Pors L, Haasjes C, van Vught L, Hoes N, Luyten G, van Rijn G, et al.
Invest Ophthalmol Vis Sci . 2024 Jan; 65(1):43. PMID: 38271188
Purpose: Although fundus photography is extensively used in ophthalmology, refraction prevents accurate distance measurement on fundus images, as the resulting scaling differs between subjects due to varying ocular anatomy. We...
7.
Tong T, Bastiaannet E, Speetjens F, Blank C, Luyten G, Jager M, et al.
Cancers (Basel) . 2023 Nov; 15(22). PMID: 38001679
Background: Uveal melanoma (UM) is a rare intraocular tumor with a dismal prognosis once metastasized. This study provides a nationwide overview and time trends of patients diagnosed with primary UM...
8.
van der Ree M, Cuculich P, Van Herk M, Hugo G, Balt J, Bates M, et al.
Front Cardiovasc Med . 2023 Oct; 10:1267800. PMID: 37799779
Background: Stereotactic arrhythmia radioablation (STAR) is a potential new therapy for patients with refractory ventricular tachycardia (VT). The arrhythmogenic substrate (target) is synthesized from clinical and electro-anatomical information. This study...
9.
Tang M, Ferreira T, Marinkovic M, Jaarsma-Coes M, Klaassen L, Vu T, et al.
Neuroradiology . 2023 May; 65(8):1271-1285. PMID: 37249621
Purpose: MRI is increasingly used in the diagnosis and therapy planning of uveal melanoma (UM). In this prospective cohort study, we assessed the radiological characteristics, in terms of anatomical and...
10.
Kinaci-Tas B, Alderliesten T, Verbraak F, Rasch C
Cancers (Basel) . 2023 Apr; 15(7). PMID: 37046660
Background: Patients with brain, head, and neck tumors experience a decline in their quality of life due to radiation retinopathy and optic neuropathy. Little is known about the dose-response relationship...